Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered
A doubling of the urine albumin-creatinine ratio (uACR), particularly above 30 mg/g and accompanied by declining eGFR, should prompt nephrology referral
Hormonal systems are highly interconnected, and changes in one pathway often ripple into others
Frequently asked questions Is 1,000 calories a day enough on semaglutide
GLUTATHIONE SHOT $50 MIC is an acronym for the compounds: L-Methionine, Inositol, Choline and (B12) cyanocobalamin
Certain medication interactions GLP-1s can interact with insulin and other diabetes medications, increasing hypoglycemia risk
